Omeros (OMER) Payables (2010 - 2026)
Omeros recorded quarterly Payables of $5.4 million in Q1 2026, up 12.66% quarter-over-quarter from $4.8 million in Q4 2025, and up 21.62% year-over-year from $4.4 million in Q1 2025.
Omeros' Payables history runs 17 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- In Q1 2026, Payables rose 21.62% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $5.4 million (up 21.62% YoY), while the FY2025 annual figure was $4.8 million, down 19.32% from the prior year.
- Payables came in at $5.4 million for Q1 2026 at Omeros, up from $4.8 million in the prior quarter.
- In the past five years, Payables ranged from a high of $17.1 million in Q3 2022 to a low of $4.4 million in Q1 2025.
- A 5-year average of $7.8 million and a median of $6.5 million in 2024 frame the typical range for Payables.
- Across the five-year window, Payables soared 70.45% in 2022 and sank 65.67% in 2023, its largest moves.
- Omeros' Payables stood at $6.0 million in 2022, then climbed by 28.77% to $7.7 million in 2023, then declined by 23.43% to $5.9 million in 2024, then dropped by 19.32% to $4.8 million in 2025, then gained by 12.66% to $5.4 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $5.4 million, $4.8 million, and $12.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.37 Mn |
| Dec 31, 2025 | 4.76 Mn |
| Sep 30, 2025 | 12.50 Mn |
| Jun 30, 2025 | 8.84 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 5.91 Mn |
| Sep 30, 2024 | 7.72 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Mar 31, 2024 | 6.18 Mn |
| Dec 31, 2023 | 7.71 Mn |
| Sep 30, 2023 | 5.87 Mn |
| Jun 30, 2023 | 9.55 Mn |
| Mar 31, 2023 | 6.45 Mn |
| Dec 31, 2022 | 5.99 Mn |
| Sep 30, 2022 | 17.09 Mn |
| Jun 30, 2022 | 10.88 Mn |
| Mar 31, 2022 | 7.35 Mn |
| Dec 31, 2021 | 13.40 Mn |
| Sep 30, 2021 | 10.03 Mn |
| Jun 30, 2021 | 9.50 Mn |
| Mar 31, 2021 | 11.50 Mn |
| Dec 31, 2020 | 4.20 Mn |
| Sep 30, 2020 | 7.02 Mn |
| Jun 30, 2020 | 8.51 Mn |
| Mar 31, 2020 | 12.96 Mn |
| Dec 31, 2019 | 5.33 Mn |
| Sep 30, 2019 | 9.70 Mn |
| Jun 30, 2019 | 6.26 Mn |
| Mar 31, 2019 | 7.12 Mn |
| Dec 31, 2018 | 6.28 Mn |
| Sep 30, 2018 | 8.85 Mn |
| Jun 30, 2018 | 11.85 Mn |
| Mar 31, 2018 | 10.18 Mn |
| Dec 31, 2017 | 6.69 Mn |
| Sep 30, 2017 | 3.68 Mn |
| Jun 30, 2017 | 2.57 Mn |
| Mar 31, 2017 | 2.41 Mn |
| Dec 31, 2016 | 2.52 Mn |
| Sep 30, 2016 | 3.99 Mn |
| Jun 30, 2016 | 5.42 Mn |
| Mar 31, 2016 | 5.33 Mn |
| Dec 31, 2015 | 6.43 Mn |
| Sep 30, 2015 | 4.58 Mn |
| Jun 30, 2015 | 4.05 Mn |
| Mar 31, 2015 | 4.61 Mn |
| Dec 31, 2014 | 4.92 Mn |
| Sep 30, 2014 | 4.16 Mn |
| Jun 30, 2014 | 5.09 Mn |
| Mar 31, 2014 | 4.93 Mn |
| Dec 31, 2013 | 2.33 Mn |
| Sep 30, 2013 | 3.36 Mn |
| Jun 30, 2013 | 4.25 Mn |
| Mar 31, 2013 | 2.61 Mn |
| Dec 31, 2012 | 2.63 Mn |
| Sep 30, 2012 | 9.08 Mn |
| Jun 30, 2012 | 7.50 Mn |
| Mar 31, 2012 | 8.44 Mn |
| Dec 31, 2011 | 7.90 Mn |
| Sep 30, 2011 | 6.92 Mn |
| Jun 30, 2011 | 4.53 Mn |
| Dec 31, 2010 | 2.79 Mn |